Le cluster Neuroendocrine Tumors (radionuclide imaging) - Neuroendocrine Tumors (secondary)
| 000130 (2003) | Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors. | |
| 000193 (1997) | Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. | |
| 000211 (1995) | Somatostatin receptor imaging: a preliminary experience in forty-nine patients. | |
| 000253 (1992) | Volume rendering and bicolour scale in double isotope studies: application to immunoscintigraphy and bone landmarking. | |
| 000039 (2011) | Contribution of SPECT/CT 111In-DTPA cisternography in the localization of an intermittent cerebrospinal fluid leak in a 3-year-old girl with congenital bone defect. | |
| 000140 (2002) | Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. | |
| 000194 (1996) | [Detection of endocrine tumors of the digestive tract. Value and limitations of scintigraphy of somatostatin receptors]. | |
| 000255 (1992) | Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence. | |
| 000007 (2013) | Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation. | |
| 000037 (2011) | Feasibility of treating irradiated bone with intramedullary delivered autologous mesenchymal stem cells. | |
| 000041 (2011) | Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent. | |
| 000053 (2010) | First bodipy-DOTA derivatives as probes for bimodal imaging. | |
| 000086 (2007) | Intramyocardial Implantation of bone marrow-derived stem cells enhances perfusion in chronic myocardial infarction: dependency on initial perfusion depth and follow-up assessed by gated pinhole SPECT. | |
| 000142 (2001) | Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. | |
| 000158 (2000) | 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. | |
| 000165 (1999) | In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors. | |
| 000168 (1999) | Factor analysis of dynamic series (FADS) in somatostatin receptor imaging. | |
| 000172 (1999) | Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. | |
| 000180 (1998) | In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma. | |
| 000184 (1997) | Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis. | |
| 000186 (1997) | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. | |
| 000207 (1996) | Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. | |
| 000228 (1994) | Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. | |
| 000279 (1990) | Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments. |
| This area was generated with Dilib version V0.5.76. |  |